T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study

T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study

Abstract Background Data on type 2 (T2)‐low severe asthma (SA) frequency is scarce, resulting in an undefined unmet therapeutic need in this patient population. Our objective was to assess the frequency and characterize the profile and burden of T2‐low SA in Greece. Methods PHOLLOW was a cross‐secti...

Full description

Saved in:
Bibliographic Details
Main Authors: Konstantinos Porpodis, Nikolaos Zias, Konstantinos Kostikas, Argyris Tzouvelekis, Michael Makris, George N. Konstantinou, Eleftherios Zervas, Stelios Loukides, Paschalis Steiropoulos, Konstantinos Katsoulis, Anastasios Palamidas, Aikaterini Syrigou, Maria Gangadi, Antonios Christopoulos, Dimosthenis Papapetrou, Fotios Psarros, Konstantinos Gourgoulianis, Eleni Tzortzaki, Stylianos K. Vittorakis, Ioannis Paraskevopoulos, Ilias Papanikolaou, Georgios Krommidas, Dimitrios Latsios, Nikolaos Tzanakis, Miltiadis Markatos, Angeliki Damianaki, Argyrios Manikas, Alexia Chatzipetrou, Dimitrios Vourdas, Ioanna Tsiouprou, Christina Papista, Marina Bartsakoulia, Nikolas Mathioudakis, Petros Galanakis, Petros Bakakos
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Clinical and Translational Allergy
Subjects:
clinically significant exacerbations
quality of life
real‐world
symptom control
treatment patterns
Online Access:https://doi.org/10.1002/clt2.70035
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/clt2.70035

Similar Items